phosphatidylcholines has been researched along with Immunoglobulin Light-chain Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blancas-Mejia, LM; Burciu, C; Franco, DA; Guzman-Villanueva, D; Hari, P; Karamanova, N; Lindsay, S; Migrino, RQ; Ramirez-Alvarado, M; Senapati, S; Truran, S; Weissig, V | 1 |
1 other study(ies) available for phosphatidylcholines and Immunoglobulin Light-chain Amyloidosis
| Article | Year |
|---|---|
Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins.
Topics: Adipose Tissue; Arterioles; Cell Survival; Cholesterol; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Gangliosides; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; NAD(P)H Dehydrogenase (Quinone); Nanoparticles; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Papaverine; Peroxynitrous Acid; Phosphatidylcholines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Superoxides; Transfection; Vascular Diseases; Vasodilator Agents | 2016 |